11649 related articles for article (PubMed ID: 10890376)
1. Large deletions of chromosome 9p in cutaneous malignant melanoma identify patients with a high risk of developing metastases. Hospital Clinic Malignant Melanoma Group, University of Barcelona.
Puig S; Castro J; Ventura PJ; Ruiz A; Ascaso C; Malvehy J; Estivill X; Mascaro JM; Lecha M; Castel T
Melanoma Res; 2000 Jun; 10(3):231-6. PubMed ID: 10890376
[TBL] [Abstract][Full Text] [Related]
2. Evidence for three tumor suppressor loci on chromosome 9p involved in melanoma development.
Pollock PM; Welch J; Hayward NK
Cancer Res; 2001 Feb; 61(3):1154-61. PubMed ID: 11221846
[TBL] [Abstract][Full Text] [Related]
3. Loss of heterozygosity in the MXI1 gene is a frequent occurrence in melanoma.
Ariyanayagam-Baksh SM; Baksh FK; Swalsky PA; Finkelstein SD
Mod Pathol; 2003 Oct; 16(10):992-5. PubMed ID: 14559981
[TBL] [Abstract][Full Text] [Related]
4. Definition of the role of chromosome 9p21 in sporadic melanoma through genetic analysis of primary tumours and their metastases. The Melanoma Cooperative Group.
Palmieri G; Cossu A; Ascierto PA; Botti G; Strazzullo M; Lissia A; Colombino M; Casula M; Floris C; Tanda F; Pirastu M; Castello G;
Br J Cancer; 2000 Dec; 83(12):1707-14. PubMed ID: 11104570
[TBL] [Abstract][Full Text] [Related]
5. Chromosome 9 deletion in sporadic and familial melanomas in vivo.
Isshiki K; Seng BA; Elder DE; Guerry D; Linnenbach AJ
Oncogene; 1994 Jun; 9(6):1649-53. PubMed ID: 8183559
[TBL] [Abstract][Full Text] [Related]
6. Chromosome 9p deletions in cutaneous malignant melanoma tumors: the minimal deleted region involves markers outside the p16 (CDKN2) gene.
Puig S; Ruiz A; Lázaro C; Castel T; Lynch M; Palou J; Vilalta A; Weissenbach J; Mascaro JM; Estivill X
Am J Hum Genet; 1995 Aug; 57(2):395-402. PubMed ID: 7668266
[TBL] [Abstract][Full Text] [Related]
7. Loss of heterozygosity on chromosomes 3, 9, 13, and 17, including the retinoblastoma locus, in uveal melanoma.
Scholes AG; Liloglou T; Maloney P; Hagan S; Nunn J; Hiscott P; Damato BE; Grierson I; Field JK
Invest Ophthalmol Vis Sci; 2001 Oct; 42(11):2472-7. PubMed ID: 11581185
[TBL] [Abstract][Full Text] [Related]
8. Frameshift mutations of RIZ, but no point mutations in RIZ1 exons in malignant melanomas with deletions in 1p36.
Poetsch M; Dittberner T; Woenckhaus C
Oncogene; 2002 May; 21(19):3038-42. PubMed ID: 12082534
[TBL] [Abstract][Full Text] [Related]
9. CDKN2A mutation and deletion status in thin and thick primary melanoma.
Cachia AR; Indsto JO; McLaren KM; Mann GJ; Arends MJ
Clin Cancer Res; 2000 Sep; 6(9):3511-5. PubMed ID: 10999737
[TBL] [Abstract][Full Text] [Related]
10. Biallelic deletions in INK4 in cutaneous melanoma are common and associated with decreased survival.
Grafström E; Egyházi S; Ringborg U; Hansson J; Platz A
Clin Cancer Res; 2005 Apr; 11(8):2991-7. PubMed ID: 15837753
[TBL] [Abstract][Full Text] [Related]
11. 9p21 deletions in primary melanoma.
Naylor MF; Brown S; Quinlan C; Pitha JV; Evertt MA
Dermatol Online J; 1997 Dec; 3(2):1. PubMed ID: 9452367
[TBL] [Abstract][Full Text] [Related]
12. Hereditary cutaneous melanoma.
Platz A; Ringborg U; Hansson J
Semin Cancer Biol; 2000 Aug; 10(4):319-26. PubMed ID: 10966854
[TBL] [Abstract][Full Text] [Related]
13. Allelotypes of primary cutaneous melanoma and benign melanocytic nevi.
Healy E; Belgaid CE; Takata M; Vahlquist A; Rehman I; Rigby H; Rees JL
Cancer Res; 1996 Feb; 56(3):589-93. PubMed ID: 8564976
[TBL] [Abstract][Full Text] [Related]
14. A defined region of loss of heterozygosity at 11q23 in cutaneous malignant melanoma.
Herbst RA; Larson A; Weiss J; Cavenee WK; Hampton GM; Arden KC
Cancer Res; 1995 Jun; 55(12):2494-6. PubMed ID: 7780954
[TBL] [Abstract][Full Text] [Related]
15. Multiple high-grade bronchial dysplasia and squamous cell carcinoma: concordant and discordant mutations.
Boyle JO; Lonardo F; Chang JH; Klimstra D; Rusch V; Dmitrovsky E
Clin Cancer Res; 2001 Feb; 7(2):259-66. PubMed ID: 11234877
[TBL] [Abstract][Full Text] [Related]
16. Chromosome 9 deletions and recurrence of superficial bladder cancer: identification of four regions of prognostic interest.
Simoneau M; LaRue H; Aboulkassim TO; Meyer F; Moore L; Fradet Y
Oncogene; 2000 Dec; 19(54):6317-23. PubMed ID: 11175346
[TBL] [Abstract][Full Text] [Related]
17. Loss of heterozygosity and homozygous deletions on 9p21-22 in melanoma.
Holland EA; Beaton SC; Edwards BG; Kefford RF; Mann GJ
Oncogene; 1994 May; 9(5):1361-5. PubMed ID: 8152796
[TBL] [Abstract][Full Text] [Related]
18. Multiple locations on chromosome 3 are the targets of specific deletions in uveal melanoma.
Cross NA; Ganesh A; Parpia M; Murray AK; Rennie IG; Sisley K
Eye (Lond); 2006 Apr; 20(4):476-81. PubMed ID: 15920570
[TBL] [Abstract][Full Text] [Related]
19. [Detailed mapping and clinical significance of loss of heterozygosity on 9p13-23 in laryngeal squamous cell carcinoma by microsatellite analysis].
Xu XF; Tang PZ; Cheng SJ
Ai Zheng; 2003 May; 22(5):452-7. PubMed ID: 12753701
[TBL] [Abstract][Full Text] [Related]
20. Melanoma ex naevo: a study of the associated naevus.
Bogdan I; Smolle J; Kerl H; Burg G; Böni R
Melanoma Res; 2003 Apr; 13(2):213-7. PubMed ID: 12690309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
